Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6428363 | 0.79 | CA2 (0.48) | CA2CA1 | |
| SCHEMBL65750 | 0.79 | CA1 (0.41) | CA2CA1CA7CA13EPHX1 | |
| SCHEMBL776069 | 0.78 | CA1 (0.35) | CA2CA1CA7CA13EPHX1 | |
| SCHEMBL9231973 | 0.77 | CA2 (0.52) | CA2CA1 | |
| SCHEMBL7662425 | 0.77 | CA2 (0.52) | CA2CA1 | |
| SCHEMBL17024208 | 0.77 | CA2 (0.46) | CA2CA1 | |
| SCHEMBL7155965 | 0.76 | CA1 (0.39) | CA2CA1CA7CA13EPHX1 | |
| SCHEMBL9150994 | 0.76 | CA1 (0.39) | CA2CA1CA7CA13EPHX1 | |
| SCHEMBL8665505 | 0.76 | CA1 (0.39) | CA2CA1CA7CA13EPHX1 | |
| SCHEMBL776230 | 0.75 | CA1 (0.33) | CA2CA1CA7CA13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109415452-B | Method for producing highly reactive isobutene homo-or copolymers | 巴斯夫欧洲公司 | 2021-10-26 | — | — | CN | claimed |
| CN-109415452-B | Method for producing highly reactive isobutene homo-or copolymers | 巴斯夫欧洲公司 | 2021-10-26 | — | — | CN | disclosed |
| CN-104969406-B | Electrolyte solution for electrochemical device and electrochemical device | 富士胶片和光纯药株式会社 | 2018-11-02 | — | — | CN | disclosed |
| EP-2625157-B1 | PREPARATION OF HOMOALLYL ALCOHOLS IN THE PRESENCE OF NONCOVALENTLY IMMOBILIZED IONIC LIQUID PHASE CATALYSTS UNDER GAS PHASE REACTION CONDITIONS | BASF SE (DE) | 2017-05-31 | — | — | EP | disclosed |
| US-8563787-B2 | Preparation of homoallyl alcohols in the presence of noncovalently supported ionic liquid phase catalysts under gas-phase reaction conditions | BASF SE (DE) | 2013-10-22 | — | — | US | disclosed |
| EP-2625157-A1 | PREPARATION OF HOMOALLYL ALCOHOLS IN THE PRESENCE OF NONCOVALENTLY IMMOBILIZED IONIC LIQUID PHASE CATALYSTS UNDER GAS PHASE REACTION CONDITIONS | BASF SE (DE) | 2013-08-14 | — | — | EP | disclosed |
| WO-2012045707-A1 | PREPARATION OF HOMOALLYL ALCOHOLS IN THE PRESENCE OF NONCOVALENTLY IMMOBILIZED IONIC LIQUID PHASE CATALYSTS UNDER GAS PHASE REACTION CONDITIONS | BASF SE (DE) | 2012-04-12 | — | — | WO | disclosed |
| US-20120083630-A1 | PREPARATION OF HOMOALLYL ALCOHOLS IN THE PRESENCE OF NONCOVALENTLY SUPPORTED IONIC LIQUID PHASE CATALYSTS UNDER GAS-PHASE REACTION CONDITIONS | BASF SE (DE) | 2012-04-05 | — | — | US | disclosed |
| US-20110253929-A1 | MIXTURES OF HYDROPHOBIC AND HYDROPHILIC IONIC LIQUIDS AND USE THEREOF IN LIQUID RING COMPRESSORS | BASF SE (DE) | 2011-10-20 | — | — | US | disclosed |
| US-5446134-A | Reacting bis(fluorosulfonyl)methane salt with cyanogen halide or pseudohalide | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 1995-08-29 | — | — | US | disclosed |
| EP-0567637-A1 | BIS(PERFLUOROSULPHONYL)METHANES, PROCESS FOR PREPARING SAME AND USES THEREOF | Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1993-11-03 | — | — | EP | disclosed |
| WO-1993009092-A1 | BIS(PERFLUOROSULPHONYL)METHANES, PROCESS FOR PREPARING SAME AND USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 1993-05-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120083630-A1 | PREPARATION OF HOMOALLYL ALCOHOLS IN THE PRESENCE OF NONCOVALENTLY SUPPORTED IONIC LIQUID PHASE CATALYSTS UNDER GAS-PHASE REACTION CONDITIONS | ADH1A, ADH1C, MGLL | CA2 4090/4885CA1 3307/4885CA7 3709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.